Tachykinin receptor-selectivity of the potential glioblastoma-targeted therapy, DOTA-[Thi8,Met(O2)11]-substance P

Loading...
Thumbnail Image

Authors

Suthiram, Janine
Pieters, Ane
Moosa, Zulfiah Mohamed
Zeevaart, Jan Rijn
Sathekge, Mike Machaba
Ebenhan, Thomas
Anderson, Ross Calley
Newton, Claire L.

Journal Title

Journal ISSN

Volume Title

Publisher

MDPI

Abstract

Please read abstract in article.

Description

The data presented in this study are available on request from the corresponding author (C.L.N.).

Keywords

Neurokinin-1 receptor, Neurokinin-2 receptor, Neurokinin-3 receptor, Mas-related G protein-coupled receptor subtype 2, Receptor selectivity, Theranostics, Glioblastoma multiforme, SDG-03: Good health and well-being

Sustainable Development Goals

SDG-03:Good heatlh and well-being
SDG-09: Industry, innovation and infrastructure

Citation

J.; Pieters, A.; Mohamed Moosa, Z.; Zeevaart, J.R.; Sathekge, M.M.; Ebenhan, T.; Anderson, R.C.; Newton, C.L. Tachykinin Receptor-Selectivity of the Potential Glioblastoma-Targeted Therapy, DOTA-[Thi8,Met(O2)11]-Substance P. International Journal of Molecular Sciences 2023, 24, 2134. https://doi.org/10.3390/ijms24032134.